2. Academic Validation
  3. Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH)

Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH)

  • Biochem Biophys Res Commun. 2025 Jan:743:151171. doi: 10.1016/j.bbrc.2024.151171.
Sangam Rajak 1,  Arunim Shah 2,  Abhishek Yadav 1,  Ambuj Shahi 1,  Sana Raza 1,  Mable M Singh 2,  Chandra P Chaturvedi 3,  Rohit A Sinha 4
Affiliations

Affiliations

  • 1 Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 226014, Lucknow, India.
  • 2 Stem Cell Research Centre, Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 226014, Lucknow, India.
  • 3 Stem Cell Research Centre, Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 226014, Lucknow, India. Electronic address: chaturvedicp75@rediffmail.com.
  • 4 Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 226014, Lucknow, India. Electronic address: anthony.rohit@gmail.com.
PMID: 39693938 DOI: 10.1016/j.bbrc.2024.151171
Abstract

Lipotoxicity is a key pathological feature in the development of non-alcoholic steatohepatitis (NASH), which is characterized by liver injury, inflammation, and fibrosis. Although lipotoxicity has been shown to induce transcriptomic alterations in liver cells, the specific role of epigenetic regulators in NASH remains elusive. In this study, we demonstrate that pharmacological inhibition of Histone Methyltransferase G9a significantly worsens NASH progression in mice, as evidenced by increased hepatic cell death, inflammation, and fibrosis. Additionally, at a cellular level both genetic and pharmacological inhibition of G9a in HepG2 cells increased their susceptibility to palmitic acid-induced Apoptosis and sub-cellular stress. Furthermore, treatment with G9a inhibitor enhanced TGF-β induced activation of primary human hepatic stellate cells (hHSCs), implicating the role of G9a in NASH pathobiology.

Keywords

Fibrosis; Histone methyltransferase G9a; Human hepatic stellate cells (hHSCs); Non-alcoholic steatohepatitis (NASH).

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z